Molecular dosimetry of endogeneous genotoxins
内源性基因毒素的分子剂量测定
基本信息
- 批准号:7893041
- 负责人:
- 金额:$ 24.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-18 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAnimal ModelAnimal TarsusArachidonate 15-LipoxygenaseArachidonate 5-LipoxygenaseArachidonic AcidsAscorbic AcidAtmospheric PressureAwardBiological MarkersCalendarCancer EtiologyCancer ModelCarbonCell modelCellsChemicalsColonColon CarcinomaColorectal CancerComplementCytidineDNADNA AdductsDNA DamageDNA Repair EnzymesDNA Sequence RearrangementDeoxycytidineDeoxyguanosineDisciplineDoseEicosanoidsEicosatetraenoic AcidsElectronsElectrospray IonizationEndothelial CellsEpithelial CellsExtracellular FluidFamilyGlutathioneGlutathione S-TransferaseHumanHydrogen PeroxideIn VitroInbred C57BL MiceIntestinesIsoprostanesLipid PeroxidationLipid PeroxidesLipidsLiquid ChromatographyMalignant NeoplasmsManuscriptsMass Spectrum AnalysisMeasurementMediatingMetabolismMethodologyModelingMolecularMonitorMusMutagensN-methylacetamide-oxotremorine MNormal tissue morphologyOxidative StressPathway interactionsPhasePlayPolyunsaturated Fatty AcidsPrizeProductionProstaglandin-Endoperoxide SynthaseProteinsRNARattusReactionReactive Oxygen SpeciesRelative (related person)ReportingResearchResearch PersonnelRiskRoleSensitivity and SpecificitySiteStructureSystemTechniquesTestingTimeTissuesUrineadductanalogcarboxylatecell typecyclooxygenase 2dosimetryenantiomerin vivoin vivo Modelinnovationinsightinstrumentationionizationmembermouse modelmultiple reaction monitoringnoveloctadecadienoic acidprogramsstable isotopetandem mass spectrometry
项目摘要
DESCRIPTION (provided by applicant): The analysis of DNA-adducts is important for molecular dosimetry studies, and for monitoring treatment options because they can provide insight into the amount of genotoxin that that has reached the DNA in the tissue under study. No specific biomarkers of endogenous lipid hydroperoxide-mediated DNA damage in vivo are available in spite of an intensive research effort spanning several decades. Our studies over the last six years have identified three heptanone-etheno-DNA-adducts that can only arise from endogenously formed lipid hydroperoxides. We have now shown that heptanone-etheno-2'-deoxyguanosine heptanone-etheno-21- deoxy-cytidine adducts are formed in the DNA of rat intestinal epithelial cells that stably express COX-2 and that the adducts are present in mammalian tissue DNA. We have also discovered a new class of cyclic glutathione (GSH)-adducts derived from endogenous lipid hydroperoxides. Lipid hydroperoxides undergo homolytic decomposition to the highly reactive bifunctional electrophile 4-oxo-2(E)-nonenal (ONE). Lipid hydroperoxide-derived ONE is responsible for the formation of both heptanone-etheno- adducts and the novel cyclic GSH-adducts. Our recent discovery that electron capture atmospheric chemical ionization mass spectrometry can be used to analyze chiral lipids with high sensitivity and specificity makes it possible to analyze the lipid hydroperoxide precursors of DNA- and glutathione- adducts. Therefore, we are poised to make some significant advances in understanding the role of oxidative stress in the etiology of cancer. We propose to address the following hypotheses: 1. Endogenous GSH-adducts and their metabolites represent a new class of biomarkers that will complement isoprostanes as biomarkers of oxidative stress. 2. Endogenous DNA-, RNA-, and cyclic GSH-adducts adducts can arise from cyclooxygenase-mediated pathways. 3. Endogenous DNA-, RNA-, and cyclic GSH-adducts can arise from 5-lipoxygenase but not 15-lipoxygenase. 4. Heptanone- etheno-DNA- and RNA-adducts, together with metabolites of endogenous cyclic GSH-adducts are dosimeters of colon cancer. The proposed research will be conducted under four specific aims. Aim 1. To examine the enzymatic formation and metabolism of endogenous lipid hydroperoxide-derived GSH- adducts. Aim 2. To compare ROS- and COX-2-mediated formation of endogenous DNA-, RNA-, and GSH-adducts with lipid hydroperoxide formation in cellular models. Aim 3. To compare ROS- and LOX- mediated formation of endogenous DNA-, RNA-, and GSH-adducts with lipid hydroperoxide formation in cellular models. Aim 4. To quantify endogenous lipid hydroperoxide-derived DNA-adducts, RNA- adducts, GSH-adducts as potential cancer biomarkers in animal models of colon cancer and in human colon tissue.
描述(由申请人提供):DNA添加剂的分析对于分子剂量学研究和监测治疗方案很重要,因为它们可以深入了解已研究组织中DNA的基因毒素量。尽管经过数十年的大量研究工作,但在体内尚无内源性脂质氢过氧介导的DNA损伤的特定生物标志物。在过去的六年中,我们的研究确定了只有内生形成的脂质氢过氧化物才能引起的三个己酮 - 乙烯-DNA-DNA添加剂。现在,我们已经表明,在大鼠肠上皮细胞的DNA中形成了己酮-2'-脱氧鸟酮-21-脱氧 - 酪蛋白加合物,稳定表达cox-2,并且在哺乳动物组织DNA中存在加合物。我们还发现了一类新的循环谷胱甘肽(GSH) - 源自内源性脂质氢过氧化物。脂质氢过氧化物对高反应性双功能电力4-oxo-2(e) - 硝酸(一个)经历均质分解。脂质氢过氧化物衍生的人是甲酮 - 乙烯加合物和新型环状GSH添加剂的形成。我们最近发现,电子捕获大气化学电离质谱法可用于分析具有高灵敏度和特异性的手性脂质,因此可以分析DNA和谷胱甘肽加合物的脂质氢过氧前体。因此,我们准备在理解氧化应激在癌症病因中的作用方面取得重大进步。我们建议解决以下假设:1。内源性GSH-添加剂及其代谢物代表了一种新的生物标志物,它们将与异丙烷相辅相成,作为氧化应激的生物标志物。 2。内源性DNA,RNA和环状GSH添加物可以来自环氧酶介导的途径。 3。内源性DNA-,RNA-和环状GSH-添加剂可能来自5-脂氧酶,而不是15-脂氧酶。 4。己酮 - 埃乙烯-DNA和RNA-ADDUCTS,以及内源环状GSH添加剂的代谢产物,是结肠癌的剂量计。拟议的研究将以四个特定目的进行。目的1。检查内源性脂质氢过氧化物加合物的酶形成和代谢。目的2。在细胞模型中,将内源性DNA,RNA和GSH添加剂的ROS-和COX-2介导的内源性DNA,RNA和GSH添加剂与脂质氢过氧化物形成进行比较。目的3。在细胞模型中,将内源性DNA,RNA和GSH添加剂的ROS-和LOX介导的形成与脂质氢过氧化物形成。目的4。量化内源性脂质氢过氧化物衍生的DNA-添加剂,RNA加合物,GSH添加剂,作为结肠癌动物模型和人类结肠组织中的潜在癌症生物标志物。
项目成果
期刊论文数量(35)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
5-Lipoxygenase-mediated endogenous DNA damage.
- DOI:10.1074/jbc.m109.011841
- 发表时间:2009-06-19
- 期刊:
- 影响因子:0
- 作者:Jian W;Lee SH;Williams MV;Blair IA
- 通讯作者:Blair IA
Targeted chiral lipidomics analysis of bioactive eicosanoid lipids in cellular systems.
- DOI:10.5483/bmbrep.2009.42.7.401
- 发表时间:2009-07-31
- 期刊:
- 影响因子:3.8
- 作者:Lee SH;Blair IA
- 通讯作者:Blair IA
20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice.
- DOI:10.1371/journal.pone.0010235
- 发表时间:2010-04-20
- 期刊:
- 影响因子:3.7
- 作者:Cooper PR;Mesaros AC;Zhang J;Christmas P;Stark CM;Douaidy K;Mittelman MA;Soberman RJ;Blair IA;Panettieri RA
- 通讯作者:Panettieri RA
Analysis of endogenous glutathione-adducts and their metabolites.
- DOI:10.1002/bmc.1374
- 发表时间:2010-01
- 期刊:
- 影响因子:1.8
- 作者:Blair, Ian A.
- 通讯作者:Blair, Ian A.
Characterization of a lipid hydroperoxide-derived RNA adduct in rat intestinal epithelial cells.
- DOI:10.1021/tx0600189
- 发表时间:2006-06
- 期刊:
- 影响因子:4.1
- 作者:P. Zhu;Seon-Hwa Lee;S. Wehrli;I. Blair
- 通讯作者:P. Zhu;Seon-Hwa Lee;S. Wehrli;I. Blair
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ian Alexander Blair其他文献
Ian Alexander Blair的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ian Alexander Blair', 18)}}的其他基金
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
黑色素瘤:靶向治疗反应的代谢生物标志物
- 批准号:
10337249 - 财政年份:2020
- 资助金额:
$ 24.88万 - 项目类别:
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
黑色素瘤:靶向治疗反应的代谢生物标志物
- 批准号:
10115684 - 财政年份:2020
- 资助金额:
$ 24.88万 - 项目类别:
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
黑色素瘤:靶向治疗反应的代谢生物标志物
- 批准号:
10565951 - 财政年份:2020
- 资助金额:
$ 24.88万 - 项目类别:
Analytical validation of frataxin proteoforms in blood as biomarkers of Friedreich's ataxia
血液中 frataxin 蛋白质形式作为弗里德赖希共济失调生物标志物的分析验证
- 批准号:
10356088 - 财政年份:2020
- 资助金额:
$ 24.88万 - 项目类别:
Analytical validation of frataxin proteoforms in blood as biomarkers of Friedreich's ataxia
血液中 frataxin 蛋白质形式作为弗里德赖希共济失调生物标志物的分析验证
- 批准号:
10582596 - 财政年份:2020
- 资助金额:
$ 24.88万 - 项目类别:
Analytical validation of frataxin proteoforms in blood as biomarkers of Friedreich's ataxia
血液中 frataxin 蛋白质形式作为弗里德赖希共济失调生物标志物的分析验证
- 批准号:
10117295 - 财政年份:2020
- 资助金额:
$ 24.88万 - 项目类别:
Asbestos fate, exposure, remediation, and adverse health effects
石棉的归宿、接触、修复和不良健康影响
- 批准号:
9530878 - 财政年份:2014
- 资助金额:
$ 24.88万 - 项目类别:
Asbestos fate, exposure, remediation, and adverse health effects
石棉的归宿、接触、修复和不良健康影响
- 批准号:
9041609 - 财政年份:2014
- 资助金额:
$ 24.88万 - 项目类别:
Asbestos fate, exposure, remediation, and adverse health effects
石棉的归宿、接触、修复和不良健康影响
- 批准号:
8651082 - 财政年份:2014
- 资助金额:
$ 24.88万 - 项目类别:
Development of Breast Cancer Risk Model Based on Estrogen Metabolomics
基于雌激素代谢组学的乳腺癌风险模型的开发
- 批准号:
8550778 - 财政年份:2012
- 资助金额:
$ 24.88万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of skeletal muscle IPMK in nutrient metabolism and exercise
骨骼肌IPMK在营养代谢和运动中的作用
- 批准号:
10639073 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Mitochondrial electron transport dysfunction: Dissecting pathomechanisms
线粒体电子传递功能障碍:剖析病理机制
- 批准号:
10679988 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Preclinical Development of a Novel Therapeutic Agent for Idiopathic Pulmonary Fibrosis
特发性肺纤维化新型治疗剂的临床前开发
- 批准号:
10696538 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers
BEASTS-为 ALD 研究人员提供支持的新型仿生肝脏平台
- 批准号:
10697452 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别: